The use of BRT in the treatment of rheumatoid arthritis

AUTHORS : Gustomesova E.N. | Gustomesova V.I. | Sobolev Yu.A.

RELEVANT UNIVERSITIES : Regional Clinical Hospital, Voronezh, Russia

YEAR : 2002 | Category : Type of application

Rheumatoid arthritis is a chronic systemic autoimmune disease of the connective tissue, accompanied mainly by damage to the peripheral joints and the development of erosive-destructive changes in them. According to the WHO, the incidence of rheumatoid polyarthritis (RA) in the population ranges from 0.6 to 1.3%, while in close relatives it reaches 3.5%. RA accounts for 10% of the total number of rheumatic diseases, and the annual incidence of new cases of the disease is about 0.02%, and women are sick much more often than men (ratio 3: 1).